| Product Code: ETC10079501 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Dhaval Chaurasia | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Vietnam Neuroblastoma Market Overview |
3.1 Vietnam Country Macro Economic Indicators |
3.2 Vietnam Neuroblastoma Market Revenues & Volume, 2021 & 2031F |
3.3 Vietnam Neuroblastoma Market - Industry Life Cycle |
3.4 Vietnam Neuroblastoma Market - Porter's Five Forces |
3.5 Vietnam Neuroblastoma Market Revenues & Volume Share, By Diagnostics, 2021 & 2031F |
3.6 Vietnam Neuroblastoma Market Revenues & Volume Share, By Treatment, 2021 & 2031F |
3.7 Vietnam Neuroblastoma Market Revenues & Volume Share, By End-User, 2021 & 2031F |
4 Vietnam Neuroblastoma Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing awareness and education about neuroblastoma among healthcare professionals and the general public in Vietnam |
4.2.2 Rising investments in healthcare infrastructure and technology for early detection and treatment of neuroblastoma |
4.2.3 Government initiatives and funding to support research and development in the field of pediatric oncology in Vietnam |
4.3 Market Restraints |
4.3.1 Limited access to advanced diagnostic tools and treatment options for neuroblastoma in Vietnam |
4.3.2 High treatment costs and financial constraints for patients and healthcare facilities |
4.3.3 Lack of specialized healthcare professionals and expertise in managing neuroblastoma cases in Vietnam |
5 Vietnam Neuroblastoma Market Trends |
6 Vietnam Neuroblastoma Market, By Types |
6.1 Vietnam Neuroblastoma Market, By Diagnostics |
6.1.1 Overview and Analysis |
6.1.2 Vietnam Neuroblastoma Market Revenues & Volume, By Diagnostics, 2021- 2031F |
6.1.3 Vietnam Neuroblastoma Market Revenues & Volume, By MIBG scan, 2021- 2031F |
6.1.4 Vietnam Neuroblastoma Market Revenues & Volume, By Imaging, 2021- 2031F |
6.1.5 Vietnam Neuroblastoma Market Revenues & Volume, By Biopsy, 2021- 2031F |
6.2 Vietnam Neuroblastoma Market, By Treatment |
6.2.1 Overview and Analysis |
6.2.2 Vietnam Neuroblastoma Market Revenues & Volume, By Surgery, 2021- 2031F |
6.2.3 Vietnam Neuroblastoma Market Revenues & Volume, By Medications, 2021- 2031F |
6.2.4 Vietnam Neuroblastoma Market Revenues & Volume, By Chemotherapy, 2021- 2031F |
6.2.5 Vietnam Neuroblastoma Market Revenues & Volume, By Radiation therapy, 2021- 2031F |
6.2.6 Vietnam Neuroblastoma Market Revenues & Volume, By Stem cell transplant, 2021- 2031F |
6.2.7 Vietnam Neuroblastoma Market Revenues & Volume, By Immunotherapy, 2021- 2031F |
6.3 Vietnam Neuroblastoma Market, By End-User |
6.3.1 Overview and Analysis |
6.3.2 Vietnam Neuroblastoma Market Revenues & Volume, By Hospitals and clinics, 2021- 2031F |
6.3.3 Vietnam Neuroblastoma Market Revenues & Volume, By Ambulatory surgical centers, 2021- 2031F |
6.3.4 Vietnam Neuroblastoma Market Revenues & Volume, By Diagnostic centers, 2021- 2031F |
6.3.5 Vietnam Neuroblastoma Market Revenues & Volume, By Research centers, 2021- 2031F |
6.3.6 Vietnam Neuroblastoma Market Revenues & Volume, By Others, 2021- 2031F |
7 Vietnam Neuroblastoma Market Import-Export Trade Statistics |
7.1 Vietnam Neuroblastoma Market Export to Major Countries |
7.2 Vietnam Neuroblastoma Market Imports from Major Countries |
8 Vietnam Neuroblastoma Market Key Performance Indicators |
8.1 Survival rates of neuroblastoma patients in Vietnam |
8.2 Number of clinical trials and research studies related to neuroblastoma conducted in Vietnam |
8.3 Adoption rate of new treatment protocols and guidelines for neuroblastoma management in Vietnamese healthcare facilities |
9 Vietnam Neuroblastoma Market - Opportunity Assessment |
9.1 Vietnam Neuroblastoma Market Opportunity Assessment, By Diagnostics, 2021 & 2031F |
9.2 Vietnam Neuroblastoma Market Opportunity Assessment, By Treatment, 2021 & 2031F |
9.3 Vietnam Neuroblastoma Market Opportunity Assessment, By End-User, 2021 & 2031F |
10 Vietnam Neuroblastoma Market - Competitive Landscape |
10.1 Vietnam Neuroblastoma Market Revenue Share, By Companies, 2024 |
10.2 Vietnam Neuroblastoma Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here